Exploring promising breakthroughs in Alzheimer's research
Join Ken Blaker, a health care and technology consultant, and Cuong Do, a health care executive, as they shed light on the latest developments in combating these challenging conditions. From the recent FDA approval of Leqembi to promising anti-neuroinflammation drugs and genetic approaches, we uncover the cutting-edge strategies that could…























